BlissCo Cannabis CorpCSE: BLIS

BlissCo Cannabis Corp Receives its Cultivars at Langley Facility

· Issued by BlissCo Cannabis Corp via CNW

/NOT FOR DISTRIBUTION IN THE U.S. OR TO U.S. NEWSWIRE SERVICES./

VANCOUVER, May 8, 2018 /CNW/ - BlissCo Cannabis Corp. (CSE: BLIS) is pleased to announce that the company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo"), has received its order of cuttings at its facility in Langley. BlissCo received the cuttings on May 2, 2018, from 7ACRES which is a Licensed Producer and wholly owned subsidiary of The Supreme Cannabis Company, Inc. (TSX.V: FIRE).

Learn More: BlissCo.com (CNW Group/BlissCo Cannabis Corp.)

These cuttings have been proven through the 7ACRES team and bred by world-renowned seed breeders Dinafem and Paradise Seeds.

"The cuttings from 7ACRES are doing well in their new environment. We are thrilled that the plants arrived so quickly, just 34 days after BlissCo was licensed on March 29, 2018. This will enable the team to start the process to earn our sales license in an expedient manner." said Damian Kettlewell, BlissCo CEO.

Statistics Canada estimates that Canadians spent about $5.7 billion on cannabis in 2017, despite the substance's pending legal status.

"BlissCo has strategically acquired a range of proven CBD strains that vary from high to low CBD levels, including a 1:1 THC:CBD profile to add to our genetic library. The cannabis cultivars received by BlissCo stay true to BlissCo's brand promise of high quality, clean and nutrient-rich dried medicinal cannabis crafted for the experience that our patients are looking for." added Kettlewell.

The Hemp Business Journal estimated that the global market for CBD will grow to $2.1 billion by 2020.

These cuttings will complement the four premium strains with high THC profiles which the company intends to purchase from its strategic partner The Supreme Cannabis Company Inc . as part of a two-year, 3,000-kilogram supply agreement.

"We are seeing incredible momentum within the BlissCo team and are beginning to attract an increasing number of world-class partners and advisors who will play a key role in helping us to serve our unique customer segment. The arrival of these cultivars is just one more critical step on the way to realizing our grand vision." said Kettlewell.

About BlissCo

BlissCo (CSE: BLIS) earned its Access to Cannabis for Medical Purposes Regulation ACMPR License to Cultivate on Thursday, March 29, 2018. BlissCo's ACMPR facility in Langley, B.C. is designed to be a high-volume packager, processor and distributor of medical cannabis and adult use cannabis when it is legal in Canada, which is currently anticipated to be by August 2018 at the earliest. BlissCo has a two - year supply agreement with The Supreme Cannabis Company Inc. (TSX.V: FIRE) to purchase 3,000 kilograms of premium dried cannabis.

BlissCo will apply to expand its license to cannabis oil production in Q2 2018 and will apply for its cannabis sales license at the earliest appropriate time. BlissCo will focus on high volume sales opportunities in the regulated medical use and adult use cannabis market in Canada when it is legal and is pursuing expansion opportunities in international markets.

On Behalf of the Board of Director

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively "forward-looking statements"). The use of any of the word "will" and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

SOURCE BlissCo Cannabis Corp.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/08/c4915.html

Damian Kettlewell, CEO, (604) 484 9119, ext. 3, damian.kettlewell@blissco.comCopyright CNW Group 2018

View original source (CNW)BlissCo Cannabis Corp on 6ix

Earlier from BlissCo Cannabis

Later from BlissCo Cannabis

All BlissCo Cannabis news releases